Pavella Therapeutics Inc. (PVLA)
Market Closed
16 Oct, 08:00 PM
$
120. 30
-7.04
-5.5285%
$
1.99B Market Cap
- P/E Ratio
- Div Yield
179,489 Volume
- Eps
$ 127.34
Previous Close 
Want to track PVLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pavella Therapeutics Inc. (PVLA) Statistics
Valuation metrics
Market Cap 1.99B
Enterprise value 1.8B
Trailing P/E (ttm) -28.73
Forward P/E -
PEG ratio -0.99
Price/Sales (ttm) -
Price/Book (mrq) 9.19
Enterprise Value/Revenue -
Enterprise Value/EBITDA -36.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 255.7K
Average volume (90 days) 247.97K
Price summary
52-Week low 68.96
52-Week high 161.38
Beta -
50-Day moving average 139.91
200-Day moving average 125.2
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:80
Last split Date 23 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.24%
Return on equity -0.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 17.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 21.18%
Book value per share (mrq) 15.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
